FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one heminapadisylate of formula (I) wherein n is equal to 2, and to pharmaceutically acceptable solvates thereof. Also, the invention refers to a pharmaceutical composition of the salt of formula (I), to a method of treating the above pathological conditions and to using the salt of formula (I) and to the pharmaceutical composition thereof.
EFFECT: what is prepared is the new salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one effective in treating the pathological pulmonary conditions, particularly asthma or chronic obstructive pulmonary disease.
11 cl, 3 dwg, 6 ex
Title | Year | Author | Number |
---|---|---|---|
NEW DOSE AND FORMULATION | 2009 |
|
RU2608713C2 |
4-(2-AMINO-1-HYDROXYETHYL)PHENOL DERIVATIVES AS β2 ADRENERGIC RECEPTOR AGONISTS | 2006 |
|
RU2440330C2 |
DERIVATIVES OF 4-(2-AMINO-1-HYDROXIETHYL)PHENOL AS β2-ADRENERGIC RECEPTOR ANTAGONISTS | 2007 |
|
RU2451675C2 |
SPECIFIC GLYCOCORTICOSTEROID COMPOUND WITH ANTIINFLAMMATORY EFFECT | 2004 |
|
RU2359973C2 |
COMBINATIONS CONTAINING ANTIMUSCARINE AGENTS AND CORTICOSTEROIDS | 2005 |
|
RU2385721C2 |
COMBINATIONS OF GLUCOPYRROLATE AND B-2 ADRENOCEPTOR ANTOGONISTS | 2005 |
|
RU2388465C2 |
ARYLALANINE DERIVATIVES AS AGONISTS OF β ADRENERGIC RECEPTOR | 2005 |
|
RU2370490C2 |
COMBINATION OF COMPOUNDS, WHICH CAN BE APPLIED IN TREATMENT OF RESPIRATORY DISEASES, ESPECIALLY CHRONICAL OBSTRUCTIVE LUNG DISEASE (COLD) AND ASTHMA | 2006 |
|
RU2414222C2 |
COMBINATIONS CONTAINING ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS | 2005 |
|
RU2404771C2 |
COMBINATIONS CONTAINING ANTIMUSCARINE AGENTS AND CORTICOSTEROIDS | 2005 |
|
RU2385156C2 |
Authors
Dates
2013-10-10—Published
2008-02-08—Filed